VIA
PRME icon

Virtus Investment Advisers’s Prime Medicine PRME Stock Holding History

Virtus Investment Advisers’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$435K Buy
117,909
+51,401
+77% +$171K 0.1% 234
2026
Q1 		$231K Buy
66,508
+1,622
+2% +$6.17K 0.06% 322
2025
Q4 		$225K Buy
+64,886
New +$289K 0.06% 362
2025
Q2 		– Sell
-54,535
Closed -$109K – 481
2025
Q1 		$109K Buy
+54,535
New +$139K 0.03% 410

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Virtus Investment Advisers's PRME Position: Q2 2026 in Review

Virtus Investment Advisers increased its Prime Medicine (PRME) stake by 77% in Q2 2026, buying an estimated $171K and bringing the position to 117,909 shares worth $435K. The position accounts for 0.1% of the portfolio, ranked #234.

Virtus Investment Advisers first reported a position in PRME in Q1 2025 and has held it in 4 quarters since. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Virtus Investment Advisers held 117,909 shares of Prime Medicine worth $435K as of Q2 2026.
  • Virtus Investment Advisers bought 51,401 Prime Medicine shares in Q2 2026, an estimated $171K.
  • Prime Medicine made up 0.1% of Virtus Investment Advisers's portfolio in Q2 2026, its #234 holding.
  • Virtus Investment Advisers first reported a position in Prime Medicine in Q1 2025 and has held it in 4 quarters since.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.